Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
New insights into the activation, interaction partners and possible functions of MK5/PRAK
Maria Perander1, Stephen M Keyse2, Ole-Morten Seternes3
1Department of Medical Biology, UiT-The Arctic University of Norway, N9037 Tromsoe, Norway.
Abstract:
MAP kinase-activated protein kinase 5 (MK5) was first described as a downstream target of the p38 MAP kinase pathway leading to its alternative acronym of p38-regulated/activated protein kinase (PRAK). However, since the discovery that MK5 is a bona fide interaction partner of the atypical MAP kinases ERK3 and ERK4 and that this interaction leads to both the activation and subcellular relocalisation of MK5, there has been considerable debate as to the relative roles of these MAPK pathways in mediating the activation and biological functions of MK5. Here we discuss recent progress in defining novel upstream components of the ERK3/ERK4 signalling pathway, our increased understanding of the mechanism by which MK5 interacts with and is activated by ERK3 and ERK4, and the discovery of novel interaction partners for MK5. Finally, we review recent literature that suggests novel biological functions for MK5 in a range of physiological and pathophysiological conditions including neuronal function and cancer.
Insights
MAP kinase-activated protein kinase 5 (MK5) is activated by ERK3/ERK4 MAP kinases, not just p38. Research clarifies MK5
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- MAP kinase-activated protein kinase 5 (MK5), also known as PRAK, was initially identified as a p38 MAP kinase pathway target.
- Recent findings reveal MK5 interacts with atypical MAP kinases ERK3 and ERK4, influencing its activation and localization.
Purpose of the Study:
- To clarify the roles of different MAP kinase pathways in MK5 activation and function.
- To review recent advancements in understanding the ERK3/ERK4-MK5 signaling axis.
Main Methods:
- Review of recent literature on MK5 signaling pathways.
- Analysis of novel upstream components and interaction partners of the ERK3/ERK4 pathway.
- Investigation of MK5 activation mechanisms by ERK3/ERK4.
Main Results:
- Progress in identifying novel upstream regulators of the ERK3/ERK4 signaling pathway.
- Enhanced understanding of how ERK3 and ERK4 activate MK5 through direct interaction.
- Discovery of new proteins that interact with MK5.
Conclusions:
- The ERK3/ERK4 pathway plays a significant role in MK5 activation and function, challenging the sole reliance on the p38 pathway.
- MK5 is implicated in diverse physiological and pathophysiological processes, including neuronal function and cancer.
- Further research is needed to fully elucidate the complex roles of MK5 in cellular signaling and disease.
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Cytoskeletal Linker Proteins - Plakins
Conjugate Addition of Enolates: Michael Addition
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Cytoskeletal Accessory Proteins
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

